Article

Implantable IOP monitor close?

The Intraocular Pressure Sensor Research Project has designed, fabricated, and evaluated in animal experiments a device for telemetric IOP monitoring, based on an implantable active microsystem.

Chicago-The Intraocular Pressure Sensor Research Project has designed, fabricated, and evaluated in animal experiments a device for telemetric IOP monitoring, based on an implantable active microsystem.

“We are close but not finished,” said Peter Walter, MD, professor of ophthalmology, RWTH Aachen University, Aachen, Germany.

The general working principle of the device has been proven, but further improvements to its stability will be necessary before it could be implanted in patients, Dr. Walter said.

The design is an IOL with an integrated microsystem to measure IOP, convert analog data to digital data, and transmit it to a reading station integrated into spectacles. The data-receiving station provides the energy to power the microchip by high frequency coupling.

The device is foldable and can be implanted through a relatively small corneal incision. Experiments in rabbits have shown that neither the implant nor the energy transfer is harmful to the eye, Dr. Walter said.

Researchers are still trying to determine the cause of fluctuations or instability in the device and are also considering several new developments, such as a non-IOL or epidural device.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.